|
Patients studied – site of infection |
|||
| Infecting organism |
Total no. of patients in this category |
Number of patients suitable for switch to oral therapy (% of patients with this infecting organism) |
Number of patients suitable for switch to oral therapy and early discharge (% of patients with this infecting organism) |
|
|
|||
| Coagulase negative staph |
44 |
13 (30%) |
9 (21%) |
| Enterococcus |
17 |
5 (29%) |
4 (24%) |
| MRSA |
110 |
63 (57%) |
38 (36%) |
| Other organisms |
7 |
3 (43%) |
3 (43%) |
| Culture negative |
33 |
9 (27%) |
8 (24%) |
|
|
|||
| Total = 211 |
93 |
62 |
|
Desai et al. BMC Infectious Diseases 2006 6:94 doi:10.1186/1471-2334-6-94 |
|||